Flezurafenib is an investigational new drug that is being evaluated by Jazz Pharmaceuticals for the treatment of cancers that are driven by oncogenic mutations that activate the RAS-RAF-MAPK signaling pathway.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.